Status:

RECRUITING

Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)

Lead Sponsor:

Montefiore Medical Center

Collaborating Sponsors:

The Bee Foundation

Conditions:

Anxiety Depression

Aneurysm Cerebral

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

The impact of cerebrovascular procedures on patients experiencing anxiety and depression is not well studied despite the high prevalence of these mental health disorders. Unruptured Intracranial aneur...

Detailed Description

This is a controlled, non-randomized, prospective cohort study with parallel arms of treatment arm with microsurgical and endovascular treatment and comparison control arm with conservative management...

Eligibility Criteria

Inclusion

  • Unruptured intracranial aneurysms (UIA)
  • mRS scores between 0-1
  • Observation Group: All patients with UIAs that are eligible for conservative management
  • Specific locations that are not good candidates for interventional treatment, such as cavernous internal carotid artery and very distally located aneurysms
  • Aneurysm size (largest dimension) is less than 4 mm
  • Treatment Group: All patients with UIAs that are decided to be treated either with endovascular or microsurgical treatments due to several reasons, such as aneurysm size above 4 mm, patient's decision

Exclusion

  • Prior history of Subarachnoid Hemorrhage (SAH)
  • Prior history of intracranial aneurysm
  • Severe comorbidities that impact the mental health of the patients, such severe psychiatric disease, and chronic end stage diseases
  • Traumatic, mycotic, dissecting, or fusiform aneurysms
  • Patients with communication barriers (does not include foreign language), developmental disability, or psychiatric illness that prevent understanding of the questions required to complete assessments
  • Patients with any physical disabilities or handicaps

Key Trial Info

Start Date :

December 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2027

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06123325

Start Date

December 1 2023

End Date

September 1 2027

Last Update

November 19 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Montefiore Medical Center

The Bronx, New York, United States, 10467